852540-82-0

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 198633-83-9 1-(3-azido-propyl)-3-bromo-benzene 
• 42287-90-1 3-(3-bromophenyl)propanoic acid 
• 615534-55-9 3-(3-bromophenyl)propionamide 
• 165803-62-3 methanesulfonic acid 3-(3-bromo-phenyl)-propyl ester 
• 14473-91-7 3-Bromocinnamic acid 
• 65537-54-4 3-(3-bromophenyl)-propan-1-ol 
• 174689-12-4 3-(3-bromophenyl)propan-1-amine 

Downstream Products

• 852540-83-1 {3-[3-(4-hydroxy-but-1-ynyl)-phenyl]-propyl}-carbamic acid tert-butyl ester 
• 1075177-55-7 C₂₃H₃₉NO₃ 
• 1206480-71-8 C₄₀H₄₆N₂O₄S 
• 1075177-56-8 (E)-3-(3-(non-4-en-5-yl)phenyl)propan-1-amine hydrochloride 
• 1098106-95-6 tert-butyl 3-(3-((2-methoxyphenyl)ethynyl)phenyl)propylcarbamate 
• 1613643-74-5 C₄₈H₆₂N₄O₆ 
• 1098108-10-1 tert-butyl 3-(3-(cyclopropylethynyl)phenyl)propylcarbamate 
• 852540-90-0 [3-(3-{5-benzenesulfonyl-5-[7-(tert-butyl-dimethyl-silanyloxymethyl)-naphthalen-2-yl]-4-oxo-pentyl}-phenyl)-propyl]-carbamic acid tert-butyl ester 
• 852540-89-7 [3-(3-{5-benzenesulfonyl-5-[7-(tert-butyl-dimethyl-silanyloxymethyl)-naphthalen-2-yl]-4-hydroxy-pentyl}-phenyl)-propyl]-carbamic acid tert-butyl ester 
• 852540-91-1 [3-(3-{5-[7-(tert-butyl-dimethyl-silanyloxymethyl)-naphthalen-2-yl]-4-oxo-pentyl}-phenyl)-propyl]-carbamic acid tert-butyl ester 
• 852540-92-2 7-{5-[3-(3-tert-butoxycarbonylamino-propyl)-phenyl]-2-oxo-pentyl}-naphthalene-2-carboxylic acid 
• 852541-12-9 (3-{3-[5-(7-hydroxymethyl-naphthalen-2-yl)-4-oxo-pentyl]-phenyl}-propyl)-carbamic acid tert-butyl ester 
• 852540-93-3 7-{5-[3-(3-amino-propyl)-phenyl]-2-oxo-pentyl}-naphthalene-2-carboxylic acid 
• 852540-84-2 {3-[3-(4-hydroxy-butyl)-phenyl]-propyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

PYRROLE mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

PYRROLE mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

ANTI-MALARIAL COMPOUNDS

The present invention provides tricyclic compounds, arylamide compounds, and other compounds, and compositions comprising the same, for treating malaria, and methods of treating malaria comprising administering such compounds to an animal.

ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

Enzymatic approach to unnatural glycosides with diverse aglycon scaffolds using glycosyltransferase VinC

Glycosyltransferase VinC was explored for a construction of glycoside libraries using dTDP-vicenisamine and structurally unrelated unnatural aglycons, and new unnatural vicenisaminides were successfully constructed. Structural elements of aglycon recognit